SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-027552
Filing Date
2021-08-09
Accepted
2021-08-09 16:11:07
Documents
14
Period of Report
2021-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10027803_8k.htm   iXBRL 8-K 25976
2 EXHIBIT 99.1 brhc10027803_ex99-1.htm EX-99.1 114045
6 image0.jpg GRAPHIC 83197
  Complete submission text file 0001140361-21-027552.txt   404207

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rckt-20210809.xsd EX-101.SCH 3935
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20210809_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20210809_pre.xml EX-101.PRE 16050
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10027803_8k_htm.xml XML 4057
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 211156583
SIC: 2834 Pharmaceutical Preparations